Stanley R. Krystek

Person

Ringoes, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies and antigen binding peptides for factor XIa inhibitors a...
- Patent number 12,065,505
- Issue date Aug 20, 2024
- Bristol-Myers Squibb Company
- Joseph M. Luettgen
- G01 - MEASURING TESTING
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,926,673
- Issue date Mar 12, 2024
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 11,813,315
- Issue date Nov 14, 2023
- Bristol-Myers Squibb Company
- Sharon Cload
- G01 - MEASURING TESTING
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,795,231
- Issue date Oct 24, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,773,178
- Issue date Oct 3, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodruggable antibodies, prodrugs thereof, and methods of use and m...
- Patent number 11,623,965
- Issue date Apr 11, 2023
- Bristol-Myers Squibb Company
- Stanley R. Krystek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 11,524,992
- Issue date Dec 13, 2022
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fibronectin type III domain proteins with enhanced solubility
- Patent number 11,512,124
- Issue date Nov 29, 2022
- Bristol-Myers Squibb Company
- Aaron P Yamniuk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fast-off rate serum albumin binding fibronectin type III domains
- Patent number 11,434,275
- Issue date Sep 6, 2022
- Bristol-Myers Squibb Company
- Stanley Richard Krystek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,261,258
- Issue date Mar 1, 2022
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses in treating immune...
- Patent number 11,254,750
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating immune diseases by administering antibody polyp...
- Patent number 11,136,406
- Issue date Oct 5, 2021
- Bristol-Myers Squibb Company
- Anish Suri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin type III domain proteins with enhanced solubility
- Patent number 10,787,498
- Issue date Sep 29, 2020
- Bristol-Myers Squibb Company
- Aaron P Yamniuk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fast-off rate serum albumin binding fibronectin type III domains
- Patent number 10,766,946
- Issue date Sep 8, 2020
- Bristol-Myers Squibb Company
- Stanley Richard Krystek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 10,584,160
- Issue date Mar 10, 2020
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding antibody polypeptides that antagonize CD40
- Patent number 10,544,228
- Issue date Jan 28, 2020
- Bristol-Myers Squibb Company
- Anish Suri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating inflammation with IL-17A/F and IL-23P19 bispeci...
- Patent number 10,358,490
- Issue date Jul 23, 2019
- Bristol-Myers Squibb Company
- Brenda L. Stevens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 10,245,302
- Issue date Apr 2, 2019
- Bristol-Myers Squibb Company
- Sharon Cload
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23...
- Patent number 9,783,606
- Issue date Oct 10, 2017
- Bristol-Myers Squibb Company
- Brenda L. Stevens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 9,493,546
- Issue date Nov 15, 2016
- Bristol-Myers Squibb Company
- Sharon Cload
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40
- Patent number 9,475,879
- Issue date Oct 25, 2016
- Bristol-Myers Squibb Company
- Anish Suri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies to IL-23 and IL-17A/F
- Patent number 8,945,553
- Issue date Feb 3, 2015
- Bristol-Myers Squibb Company
- Brenda L. Stevens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 8,853,154
- Issue date Oct 7, 2014
- Bristol-Myers Squibb Company
- Sharon Cload
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metalloprotease highly expressed in the testis, MMP-29
- Patent number 7,285,633
- Issue date Oct 23, 2007
- Bristol-Myers Squibb Company
- Shujian Wu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Crystallographic structure of the androgen receptor ligand binding...
- Patent number 7,225,083
- Issue date May 29, 2007
- Bristol-Myers Squibb Company
- Roberto Weinmann
- G01 - MEASURING TESTING
Information Patent Grant
Polynucleotides encoding three novel human cell surface proteins wi...
- Patent number 7,223,558
- Issue date May 29, 2007
- Bristol-Myers Squibb Company
- Shujian Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystallographic structure of the androgen receptor ligand binding...
- Patent number 6,795,776
- Issue date Sep 21, 2004
- Bristol-Myers Squibb Company
- Roberto Weinmann
- G01 - MEASURING TESTING
Information Patent Grant
Polynucleotides encoding a novel metalloprotease, MP-1
- Patent number 6,642,041
- Issue date Nov 4, 2003
- Bristol-Meyers Squibb Company
- Jian Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
- Publication number 20240316161
- Publication date Sep 26, 2024
- Bristol-Myers Squibb Company
- Sharon CLOAD
- G01 - MEASURING TESTING
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20240239909
- Publication date Jul 18, 2024
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20240124597
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20230312686
- Publication date Oct 5, 2023
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODRUGGABLE ANTIBODIES, PRODRUGS THEREOF, AND METHODS OF USE AND M...
- Publication number 20230295346
- Publication date Sep 21, 2023
- Bristol-Myers Squibb Company
- Stanley R. Krystek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20230145413
- Publication date May 11, 2023
- Bristol-Myers Squibb Company
- Stanley Richard KRYSTEK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AND ANTIGEN BINDING PEPTIDES FOR FACTOR XIA INHIBITORS A...
- Publication number 20220220220
- Publication date Jul 14, 2022
- Bristol-Myers Squibb Company
- Joseph M. Luettgen
- G01 - MEASURING TESTING
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220169742
- Publication date Jun 2, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220153856
- Publication date May 19, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220144962
- Publication date May 12, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FIBRONECTIN TYPE III DOMAIN PROTEINS WITH ENHANCED SOLUBILITY
- Publication number 20210070840
- Publication date Mar 11, 2021
- Bristol-Myers Squibb Company
- Aaron P Yamniuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20210054090
- Publication date Feb 25, 2021
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20200283505
- Publication date Sep 10, 2020
- Bristol-Myers Squibb Company
- Stanley Richard KRYSTEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20200262893
- Publication date Aug 20, 2020
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF TREATING IMMUNE DISEASES BY ADMINISTERING ANTIBODY POLY...
- Publication number 20200199244
- Publication date Jun 25, 2020
- Bristol-Myers Squibb Company
- Anish SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20200157233
- Publication date May 21, 2020
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
- Publication number 20190307855
- Publication date Oct 10, 2019
- Bristol-Myers Squibb Company
- Sharon CLOAD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20190077844
- Publication date Mar 14, 2019
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGGABLE ANTIBODIES, PRODRUGS THEREOF, AND METHODS OF USE AND M...
- Publication number 20190055321
- Publication date Feb 21, 2019
- Bristol-Myers Squibb Company
- Stanley R. Krystek
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20180258158
- Publication date Sep 13, 2018
- Bristol-Myers Squibb Company
- Stanley Richard KRYSTEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IL-17A/F AND IL-23p19 BISPECIFIC ANTIBODIES AND METHODS OF USING TH...
- Publication number 20180037645
- Publication date Feb 8, 2018
- Brenda L. Stevens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
- Publication number 20170088602
- Publication date Mar 30, 2017
- Bristol-Myers Squibb Company
- Sharon CLOAD
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40
- Publication number 20170015754
- Publication date Jan 19, 2017
- Bristol-Myers Squibb Company
- Anish SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FIBRONECTIN TYPE III DOMAIN PROTEINS WITH ENHANCED SOLUBILITY
- Publication number 20150368319
- Publication date Dec 24, 2015
- Bristol-Myers Squibb Company
- Aaron P Yamniuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYNUCLEOTIDES ENCODING ANTIBODIES
- Publication number 20150099278
- Publication date Apr 9, 2015
- Bristol-Myers Squibb Company
- Brenda L. Stevens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AND METHODS OF USING THE SAME
- Publication number 20150086552
- Publication date Mar 26, 2015
- Bristol-Myers Squibb Company
- Brenda L. Stevens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
- Publication number 20150072919
- Publication date Mar 12, 2015
- Bristol-Myers Squibb Company
- Sharon CLOAD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40
- Publication number 20140099317
- Publication date Apr 10, 2014
- DOMANTIS LIMITED
- Anish Suri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AND METHODS OF USING THE SAME
- Publication number 20130315911
- Publication date Nov 28, 2013
- Bristol-Myers Squibb Company
- Brenda L. Stevens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I
- Publication number 20110077395
- Publication date Mar 31, 2011
- Bristol -Myers Squibb Company
- James J. Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stanley R. Krystek

Person

Patents Grantslast 30 patents

Antibodies and antigen binding peptides for factor XIa inhibitors a...

Antagonistic CD40 monoclonal antibodies and uses thereof

Fibronectin based scaffold domain proteins that bind to myostatin

Antagonistic CD40 monoclonal antibodies and uses thereof

Antagonistic CD40 monoclonal antibodies and uses thereof

Prodruggable antibodies, prodrugs thereof, and methods of use and m...

Glypican-3-binding fibronectin based scaffold molecules

Fibronectin type III domain proteins with enhanced solubility

Fast-off rate serum albumin binding fibronectin type III domains

Antagonistic CD40 monoclonal antibodies and uses thereof

Antagonistic CD40 monoclonal antibodies and uses in treating immune...

Methods of treating immune diseases by administering antibody polyp...

Fibronectin type III domain proteins with enhanced solubility

Fast-off rate serum albumin binding fibronectin type III domains

Glypican-3-binding fibronectin based scaffold molecules

Nucleic acids encoding antibody polypeptides that antagonize CD40

Methods of treating inflammation with IL-17A/F and IL-23P19 bispeci...

Fibronectin based scaffold domain proteins that bind to myostatin

Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23...

Fibronectin based scaffold domain proteins that bind to myostatin

Antibody polypeptides that antagonize CD40

Bispecific antibodies to IL-23 and IL-17A/F

Fibronectin based scaffold domain proteins that bind to myostatin

Metalloprotease highly expressed in the testis, MMP-29

Crystallographic structure of the androgen receptor ligand binding...

Polynucleotides encoding three novel human cell surface proteins wi...

Crystallographic structure of the androgen receptor ligand binding...

Polynucleotides encoding a novel metalloprotease, MP-1

Patents Applicationslast 30 patents

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

PRODRUGGABLE ANTIBODIES, PRODRUGS THEREOF, AND METHODS OF USE AND M...

FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS

ANTIBODIES AND ANTIGEN BINDING PEPTIDES FOR FACTOR XIA INHIBITORS A...

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

FIBRONECTIN TYPE III DOMAIN PROTEINS WITH ENHANCED SOLUBILITY

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

METHODS OF TREATING IMMUNE DISEASES BY ADMINISTERING ANTIBODY POLY...

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

PRODRUGGABLE ANTIBODIES, PRODRUGS THEREOF, AND METHODS OF USE AND M...

FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS

IL-17A/F AND IL-23p19 BISPECIFIC ANTIBODIES AND METHODS OF USING TH...

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40

FIBRONECTIN TYPE III DOMAIN PROTEINS WITH ENHANCED SOLUBILITY

POLYNUCLEOTIDES ENCODING ANTIBODIES

BISPECIFIC ANTIBODIES AND METHODS OF USING THE SAME

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40

BISPECIFIC ANTIBODIES AND METHODS OF USING THE SAME

INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I